Skip to content
Assyro AI
Assyro eCTD

Clinical Trial Application (CTA) Software, Health Canada eCTD

Build each CTA and CTA amendment sequence with the Canadian Module 1 and validate it against Health Canada's eCTD rules. For sponsors filing in-house and consultancies filing for clients.

CTA Filing Workflow

See where CTA filings lose time across drafting, amendments, validation, and readiness.

  • Write the Canadian Module 1 for Each CTA Sequence

    Assyro writes ca-regional.xml to Health Canada's Module 1 schema 2.2 with the CTA regulatory activity type.

  • Stop Schema Errors Before the Build

    A Module 1 that does not match the Canadian schema is stopped before the sequence is built.

  • Validate Against Health Canada's Rules

    Each sequence is checked against Health Canada's eCTD validation rules, version 5.3.

  • Keep the Lifecycle in Order

    Each sequence records the sequence it relates to, so the dossier's history stays readable.

CTA Filing Controls and Capacity

Keep submission growth controlled with clearer ownership, better traceability, and consistent execution across active programs.

  • Maintain Audit-Ready CTA Records

    CTA sequences are checked against Health Canada's Module 1 schema 2.2 and eCTD validation rules version 5.3, with audit trails and role-based access.

  • Manage More CTA Programs With the Same Team Size

    Track Health Canada correspondence and commitments in Assyro RIM

Questions About CTA Submission Software

Practical questions sponsors and consultancies ask about Health Canada CTAs.

Agent CTA Background

See Your Next CTA Sequence in Assyro.